albicans strains independent of their azole resistance pattern. HYP was more efficient at low fungal concentration and DMMB at higher concentrations. Medically important yeast are found on humans and other warm-blooded animals and in the environments they inhabit. Candida species are ubiquitous yeast being found in the Hormones antagonist normal biota of the alimentary tract of mammals and mucocutaneous membranes of humans.[1] In health care workers, in immunocompromised patients, and in individuals living in warm and humid climates, Candida albicans may be cultured even from glabrous skin. C. albicans is the organism most commonly associated with superficial candidiasis.[2]

Oral and vaginal candidiasis are among the most common opportunistic infections

caused by C. albicans.[3] Alterations of the immune status and the use of dental prosthesis are the main predisposing factors for these infections.[4] As the recurrence rate of candidiasis is high, systemic azole antifungal therapy has been widely used. That is the reason why azole-resistant oropharyngeal, oesophageal and vaginal candidiasis are a refractory form of the opportunistic infection occurring particularly in HIV-infected patients but also in denture wearers. The therapy of choice for candidiasis is a course of systemic antifungal agents such as the azole antifungal fluconazole or echinocandins.[5] These therapies are effective, but recurrence of candidiasis is common. In addition, the concomitant DMXAA nmr risk of antifungal resistance, azoles interactions with other drugs and organ toxicity are potential adverse events. All these reasons justify the necessity of new therapeutic strategies. Antimicrobial photodynamic therapy (aPDT) is an emerging alternative to treat infections based on the use of photosensitisers (PSs) in combination with visible light of the appropriate wavelength matched to an absorption band.

Upon exposure Resminostat to light of the appropriate wavelength, the PS molecule absorbs light energy and is photoexcited to its first electronically excited singlet state which, through a cascade of events, induces oxidative damage to essential cell components, leading to cytotoxicity.[6] Several studies have demonstrated in vitro[7-10] and in vivo[11-13] the utility of aPDT for the inactivation of C. albicans using a variety of photosensitising agents and light activation sources. Nevertheless, the efficacy against fluconazole-resistant strains has received little attention. Using a porphyrin-based PS activated in the blue-light region, Dovigo et al. [14] found that azole-resistant Candida strains were more resistant to the action of aPDT in vitro than azole-sensitive strains. The opposite conclusion was reached by Mang et al. [15], who found that fluconazole- and amphotericin B-resistant Candida strains isolated from AIDS patients were equally susceptible to in vitro Photofrin-PDT than non-resistant strains.